Top

Published in:

01-10-2020 | Conjunctivitis | Case Report

Kawasaki Disease Features and Myocarditis in a Patient with COVID-19

Authors: Joanne S. Chiu, Manuella Lahoud-Rahme, David Schaffer, Ari Cohen, Margaret Samuels-Kalow

Published in: Pediatric Cardiology | Issue 7/2020

Abstract

A 10-year-old male with prolonged fever, rash, and conjunctivitis presented to the emergency department with concern for Kawasaki disease, found to have myocarditis and PCR positive for SARS-CoV-2.

Available only for authorised users

Dong Y, Mo X, Hu Y et al (2020) Epidemiology of COVID-19 among children in China. Pediatrics. https://doi.org/10.1542/peds.2020-0702CrossRefPubMedPubMedCentral

Jones VG, Mills M, Suarez D et al (2020) COVID-19 and Kawasaki Disease: novel virus and novel case. Hosp Pediatr 10(6):537–540CrossRefPubMed

Lu X, Zhang L, Du H et al (2020) SARS-CoV-2 infection in children. N Engl J Med 382:1663–1665PubMed

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846–848CrossRefPubMed

Zeng JH, Liu YX, Yuan J et al (2020) First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. https://doi.org/10.1007/s15010-020-01424-5CrossRefPubMedPubMedCentral

Hu H, Ma F, Wei X, Fang Y (2020) Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa190CrossRefPubMedPubMedCentral

Inciardi RM, Lupi L, Zaccone G et al (2020) Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1096CrossRefPubMedPubMedCentral

Printz BF, Sleeper LA, Newburger JW et al (2011) Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 57:86–92PubMedPubMedCentral

Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med 382(18):1708–1720PubMed

Title: Kawasaki Disease Features and Myocarditis in a Patient with COVID-19
Authors: Joanne S. Chiu
Manuella Lahoud-Rahme
David Schaffer
Ari Cohen
Margaret Samuels-Kalow
Publication date: 01-10-2020
Publisher: Springer US
Keywords: Conjunctivitis
Myocarditis
Tachyarrythmia
SARS-CoV-2
COVID-19
Kawasaki Disease
Kawasaki Disease
Kawasaki Disease
Published in: Pediatric Cardiology / Issue 7/2020
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-020-02393-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Kawasaki Disease Features and Myocarditis in a Patient with COVID-19

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2020

Serum Sirolimus Levels After Implantation of Third Generation Drug Eluting Cobalt Chromium Coronary Stent in Ductus Arteriosus in Neonates with Duct-Dependent Pulmonary Circulation

Tracheoplasty for Patients with Pulmonary Artery Sling and Tracheal Stenosis: A Meta-Analysis

The Spectrum of Cardiac Anomalies Associated with Heterotaxy: A Single-Center Study of a Large Series Based on Computed Tomography

QT Variability Index is Correlated with Autonomic Nerve Activity in Healthy Children

A Quality Improvement Initiative to Reduce Surgical Site Infections in Patients Undergoing Delayed Sternal Closure After Pediatric Cardiac Surgery

The Effect of Perioperative Administration of Treprostinil in Infants with Non-restrictive Ventricular Septal Defect and Severe Pulmonary Arterial Hypertension

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page